NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market on Tuesday an 11 percent increase year over year for its fourth quarter.

The San Diego-based life sciences informatics firm reported GAAP revenues of $44.2 million for the three months ended Dec. 31, 2012 compared to $39.8 million in the year-ago period, beating the average Wall Street estimate of $43.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.